Trial Begins Over J&J Subsidiary’s Anti-Psychotic Drug
An attorney for the state of Arkansas has asked jurors to hold a Johnson & Johnson subsidiary financially liable for allegedly concealing risks associated with its anti-psychotic drug Risperdal.